Not too much relevance as RAP is a non invasive diagnostic tool. It is a Class 2 medical device. It satisfies safety. It just has to satisfy efficacy.
It is expected that efficacy will be about an 80% accuracy rate which is the same level as the local doctor. We are already at 95% and above.
- Forums
- ASX - By Stock
- RAP
- Interesting read.
Interesting read., page-5
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)